Joseph C. Scodari - Jul 1, 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Joseph C. Scodari
Stock symbol
ACXP
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/6/2021, 04:15 PM
Previous filing
Jun 24, 2021
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +50K $0.00 50K Jul 1, 2021 Common Stock 50K $6.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.